NDC 51079-935-01 - Triamterene and Hydrochlorothiazide

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
51079-935
Requested NDC
51079-935-01
Package NDCs from labels
51079-935-01, 51079-935-20
Manufacturer
Mylan Institutional Inc.
Effective date
2019-11-11
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Triamterene and Hydrochlorothiazide - Mylan Institutional Inc.Mylan Institutional Inc.2019-11-11HUMAN PRESCRIPTION DRUG LABEL
National Council for Prescription Drug Programs indexing - billing unitNational Council for Prescription Drug Programs2012-07-24Indexing - Billing Unit

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
51079-935-01EA - Each51079-935dbabaf4f-3812-4045-a890-4b8350a7866912012-07-24
51079-935-20EA - Each51079-935beaf091e-44c9-4fc0-9827-70dfc404926412012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
HYDROCHLOROTHIAZIDEACTIVE INGREDIENT0J48LPH2THTRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
TRIAMTERENEACTIVE INGREDIENTWS821Z52LQTRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
HYDROCHLOROTHIAZIDEACTIVE MOIETY0J48LPH2THTRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
TRIAMTERENEACTIVE MOIETYWS821Z52LQTRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UTRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
D&C YELLOW NO. 10INACTIVE INGREDIENT35SW5USQ3GTRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDTRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQKTRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
FD&C RED NO. 40INACTIVE INGREDIENTWZB9127XOATRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
FERRIC OXIDE YELLOWINACTIVE INGREDIENTEX438O2MRTTRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F357TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
GELATININACTIVE INGREDIENT2G86QN327LTRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1ATRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
POLYSORBATE 80INACTIVE INGREDIENT6OZP39ZG8HTRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
SODIUM BICARBONATEINACTIVE INGREDIENT8MDF5V39QOTRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JTRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPTRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 176 · 3,503 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Eyewash Station Additive ConcentrateCHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOLEncon Safety Products, Inc.b5a62567-c9f1-0492-e053-2a95a90ab2472026-11-05WarningsExact identifier
unii: 6DC9Q167V3
COOLA 70 PERCENT PLUS ORGANIC MINERAL BODY SUNSCREEN SPF50TITANIUM DIOXIDE, ZINC OXIDECOOLA, LLCcb95c712-1680-4040-e053-2995a90af0042026-11-04WarningsExact identifier
unii: 15FIX9V2JP
HydrochlorothiazideHYDROCHLOROTHIAZIDEPD-Rx Pharmaceuticals, Inc.c182b6a9-1a31-45ee-9cea-a557c99f5db72026-11-04Warnings, Adverse reactionsExact identifier
unii: 0J48LPH2TH
Vertra Ehukai Beige Sunscreen Face Stick Broad Spectrum SPF 38TITANIUM DIOXIDEEai-jr 286, Inc303d5d5a-4c7a-1e23-e063-6294a90a0e582026-11-04WarningsExact identifier
unii: 15FIX9V2JP
Vertra Mick Fanning Signature Foundation Sunscreen Face Stick SPF 35 Coolangatta BeigeTITANIUM DIOXIDEEAI-JR 286, Inc.b9ea12e8-6ed9-d805-e053-2a95a90aa1072026-11-04WarningsExact identifier
unii: 15FIX9V2JP
Vertra Pearl White Face Stick SPF 50PADIMATE O, TITANIUM DIOXIDEEai-jr 286, Incb69a75e0-8724-35ae-e053-2a95a90a5f342026-11-04WarningsExact identifier
unii: 15FIX9V2JP
Vertra S Dorian Kona Gold Signature Face Stick SPF 38TITANIUM DIOXIDEEai-jr 286, Incb6c316c3-661b-6428-e053-2a95a90a1a6b2026-11-04WarningsExact identifier
unii: 15FIX9V2JP
HydrochlorothiazideHYDROCHLOROTHIAZIDEChartwell RX, LLC4e43dd27-3f4b-4205-a26e-6ecaa82813472026-11-03Warnings, Adverse reactionsExact identifier
unii: 0J48LPH2TH
Losartan Potassium and HydrochlorothiazideLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEBryant Ranch Prepackb4f5dd93-5f44-4c8c-9e3b-89ab1fa5a7fd2026-11-03Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 0J48LPH2TH
HydrochlorothiazideHYDROCHLOROTHIAZIDEA-S Medication Solutions98a58b54-bcf2-4726-800a-facf48d9155f2026-11-03Warnings, Adverse reactionsExact identifier
unii: 0J48LPH2TH
TriamtereneTRIAMTERENEAdvagen Pharma Ltd11380f30-9c0f-4397-b5a7-2ed66611be732026-11-02Warnings, Adverse reactionsExact identifier
unii: WS821Z52LQ
HydrochlorothiazideHYDROCHLOROTHIAZIDEPD-Rx Pharmaceuticals, Inc.1dc47186-3ecf-456f-b6d6-ba0f75c2504b2026-11-02Warnings, Adverse reactionsExact identifier
unii: 0J48LPH2TH
Lisinopril and HydrochlorothiazideLISINOPRIL AND HYDROCHLOROTHIAZIDECoupler LLC5f4e3bc8-2810-f1ae-e063-6394a90a97252026-11-02Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 0J48LPH2TH
Stomachin AntacidMAGNESIUM CARBONATE AND SODIUM BICARBONATEChang Kuo Chou Pharmaceutical Co., Ltd.60fa0650-8785-4cb3-8f88-1a437296252f2026-11-02WarningsExact identifier
unii: 8MDF5V39QO
HERA SILKYSTAY FOUNDATION 34W1TITANIUM DIOXIDEAmorepacific Corporation5f3ef340-c68e-1790-e063-6394a90a44aa2026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 35C1TITANIUM DIOXIDEAmorepacific Corporation5f40c97f-b90e-bec7-e063-6394a90ae5db2026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 35N1TITANIUM DIOXIDEAmorepacific Corporation5f40f46b-c6b2-df1f-e063-6394a90afd962026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 37W1TITANIUM DIOXIDEAmorepacific Corporation5f4105f3-d08b-edb5-e063-6394a90ad28b2026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 39N1TITANIUM DIOXIDEAmorepacific Corporation5f41120a-521a-f5ac-e063-6394a90ac0212026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 41W1TITANIUM DIOXIDEAmorepacific Corporation5f4158f0-c743-29c2-e063-6394a90ac7212026-11-01WarningsExact identifier
unii: 15FIX9V2JP

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.